Rankings
▼
Calendar
CTMX Q1 2016 Earnings — CytomX Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
CTMX
CytomX Therapeutics, Inc.
$822M
Q1 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$2M
Gross Profit
$2M
100.0% margin
Operating Income
-$16M
-727.9% margin
Net Income
-$16M
-721.1% margin
EPS (Diluted)
$-0.44
QoQ Revenue Growth
+11.8%
Cash Flow
Operating Cash Flow
-$6M
Free Cash Flow
-$6M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$192M
Total Liabilities
$79M
Stockholders' Equity
$113M
Cash & Equivalents
$68M
← FY 2016
All Quarters
Q2 2016 →